Corstasis Therapeutics to Present Pivotal Trial Data on Novel Bumetanide Nasal Spray at American Heart Association Scientific Sessions 2024

New data highlights the safety and efficacy of a new outpatient self-administered therapy intended to assist in the management of fluid overload in CHF, liver, and kidney disease patients Read More

Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute
Picton Mahoney Asset Management Announces Monthly Distribution for Picton Mahoney Fortified Income Alternative Fund Exchange Traded Fund Units, Picton Mahoney Fortified Special Situations Alternative Fund Exchange Traded Fund Units, Picton Mahoney Fortifi
Loonie watch: Sub-70 cent Canadian dollar inching closer into view

New York judge rejects state efforts to shutter bitcoin mine over climate concerns
Cartier Closes Private Placement Financing